Comera Life Sciences (CMRA) News Today → The most important AI company you've never heard of (From Manward Press) (Ad) Free CMRA Stock Alerts $0.02 0.00 (0.00%) (As of 05/15/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 13 at 12:37 AM | msn.comCarisma Therapeutics to Join Citizens JMP Life Sciences ConferenceJanuary 31, 2024 | msn.comComera Life Sciences Announces Sweeping Workforce TerminationJanuary 4, 2024 | finance.yahoo.comComera Life Sciences Announces Bridge Financing and Exercise of Take Private OptionJanuary 4, 2024 | finance.yahoo.comComera Life Sciences Announces Bridge Financing and Exercise of Take Private OptionDecember 6, 2023 | msn.comComera Life Sciences to explore strategic alternativesDecember 6, 2023 | finance.yahoo.comComera Life Sciences Announces Process Exploring Strategic AlternativesNovember 26, 2023 | benzinga.comComera Life Sciences Stock (NASDAQ:CMRA), Analyst Ratings, Price Targets, PredictionsNovember 14, 2023 | finance.yahoo.comComera Life Sciences Designates Dorothy Clarke to Board of DirectorsNovember 13, 2023 | finance.yahoo.comComera Life Sciences Appoints Dorothy Clarke to Board of DirectorsNovember 9, 2023 | msn.comComera Life Sciences GAAP EPS of -$0.10, revenue of $0.14MNovember 9, 2023 | finance.yahoo.comComera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business HighlightsOctober 18, 2023 | finance.yahoo.comComera Life Sciences Advancing Subcutaneous Monoclonal Antibody FormulationsOctober 16, 2023 | finance.yahoo.comComera Life Sciences Presents SQore™ Platform Technology Data at PODD: Partnerships in Drug Delivery ConferenceSeptember 13, 2023 | benzinga.comMassive Insider Trade At Comera Life SciencesSeptember 12, 2023 | benzinga.com10% Owner At This Health Care Company Buys $1.05M of StockSeptember 12, 2023 | finance.yahoo.comComera Life Sciences Announces the Completion of $4.1 Million Private PlacementAugust 16, 2023 | finance.yahoo.comComera Study Shows Caffeine’s Ability to Reduce Viscosity in AntibodiesAugust 16, 2023 | finance.yahoo.comComera Life Sciences Announces Publication of Study Reinforcing Caffeine’s Viscosity Reducing CapabilitiesAugust 10, 2023 | finance.yahoo.comComera Life Sciences Reports Financial Results for Second Quarter 2023 and Recent Business HighlightsAugust 8, 2023 | finance.yahoo.comComera Life Sciences Boosts SQore Platform PatentsAugust 8, 2023 | finance.yahoo.comComera Life Sciences Significantly Expands Intellectual Property Portfolio Strengthening the Proprietary SQore™ PlatformAugust 2, 2023 | finance.yahoo.comComera Life Sciences Announces $4.1 Million Private PlacementAugust 1, 2023 | finance.yahoo.comComera Life Sciences Announces $4.1 Million Private PlacementJuly 24, 2023 | finance.yahoo.comComera Partners with Quality Chemical Laboratories to Strengthen Supply ChainJuly 15, 2023 | seekingalpha.comCMRA Comera Life Sciences Holdings, Inc.May 11, 2023 | finance.yahoo.comComera Life Sciences Reports Financial Results for First Quarter 2023 and Recent Business HighlightsMay 11, 2023 | finance.yahoo.comComera Life Sciences Reports Financial Results for First Quarter 2023 and Recent Business HighlightsApril 27, 2023 | finance.yahoo.comComera Life Sciences to Participate in Four Upcoming ConferencesApril 3, 2023 | finance.yahoo.comComera Life Sciences Announces Expansion of Patent Portfolio Underlying Core Excipient TechnologyMarch 16, 2023 | msn.comComera Life Sciences GAAP EPS of -$0.18, revenue of $0.15MMarch 16, 2023 | finance.yahoo.comComera Life Sciences Reports Financial Results for Fourth Quarter and Full Year 2022 and Recent Business HighlightsMarch 16, 2023 | finance.yahoo.comComera Life Sciences Reports Financial Results for Fourth Quarter and Full Year 2022 and Recent Business HighlightsJanuary 31, 2023 | proactiveinvestors.comComera Life Sciences shares details of recent private placementJanuary 12, 2023 | finance.yahoo.comComera Life Sciences to Present at 22nd Annual PepTalk ConferenceJanuary 5, 2023 | finance.yahoo.comComera Life Sciences to Present at Upcoming Biotech Showcase Investor ConferenceJanuary 4, 2023 | finance.yahoo.comComera Life Sciences Closes $3.6 Million Private Placement Priced At-the-Market under Nasdaq RulesDecember 1, 2022 | uk.finance.yahoo.comComera Life Sciences Holdings, Inc. (NASDAQ:CMRA) insiders are still down US$76k after purchasing last year, recent gain helped regain some lossesNovember 18, 2022 | finance.yahoo.comComera Life Sciences to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor ConferenceNovember 10, 2022 | finance.yahoo.comComera Life Sciences Reports Financial Results for Third Quarter 2022 and Business HighlightsNovember 9, 2022 | finance.yahoo.comComera Life Sciences Appoints Janice Marie McCourt as Chief Business OfficerOctober 18, 2022 | finance.yahoo.comComera Life Sciences Announces Favorable Preclinical Results of Lead SQore Excipient in SEQURUS-2 StudyOctober 4, 2022 | finance.yahoo.comComera Life Sciences Expands Woburn OperationsSeptember 14, 2022 | wsj.comComera Life Sciences Holdings Inc.September 13, 2022 | nasdaq.comComera Life Sciences Holdings Spikes 38%August 31, 2022 | finance.yahoo.comComera Life Sciences Announces Up To $15 million Purchase Agreement with Arena Business SolutionsAugust 12, 2022 | seekingalpha.comComera Life Sciences GAAP EPS of -$1.14, revenue of $0.15MAugust 11, 2022 | finance.yahoo.comComera Life Sciences to Present Topline Results of SEQURUS-2 Study at 14th Annual Bioprocessing SummitAugust 10, 2022 | finance.yahoo.comComera Life Sciences Provides Business Highlights and Reports Financial Results for the Second Quarter 2022July 26, 2022 | marketbeat.comTrading was temporarily halted for "CMRA" at 01:07 PM with a stated reason of "LULD pause."July 12, 2022 | investing.comComera Life Sciences Holdings Inc (CMRA) Get Comera Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CMRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Wall Street legend who predicted 2021 tech crash issues new warning (Ad)People around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And he just issued an urgent WARNING for some of the most popular stocks in U.S. history. Watch his stock warning right here, 100% free of charge CMRA Media Mentions By Week CMRA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CMRA News Sentiment▼0.590.55▲Average Medical News Sentiment CMRA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CMRA Articles This Week▼10▲CMRA Articles Average Week Get Comera Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CMRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: HSTO News Today BLPH News Today SXTC News Today APVO News Today ADTX News Today EVFM News Today SPRC News Today EVLO News Today SBFM News Today ATHX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CMRA) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsTop 5 AI Stocks to Buy for 2024Market Moving TrendsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportPharma Giant Makes Deal with a "Drug Smuggler"Behind the MarketsTop 5 Tech Stocks to Buy for 2024Daily Market Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Comera Life Sciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
